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Abstract
Background: Urinary tract infections (UTIs) are common in general practice, and antibiotic
resistance is often seen. Urine cultures are advised by the Dutch national UTI guideline for
patients at high risk of UTI complications. Prudent use of antibiotics and taking into account
national guidelines and urine culture results are important to combat antibiotic resistance in
general practice. Aim: To identify subgroups of UTI patients in which the use of urine
cultures and antibiotic prescriptions deviates from the national guidelines. Methods: We
investigated associations of several characteristics with urine culture orders in patients with
UTI in 2015 from seven Dutch general practices (n= 1295). These included subgroups at risk
for UTI complications, comorbidities, age and history of UTI recurrence. In addition, we
assessed the level of adherence to the guideline for antibiotic prescriptions in subgroups at
risks for UTI complications. Findings: Urine cultures were ordered in 17% (n= 221) of
patients, more frequently in high-risk patients (32%) than in low-risk patients (7%), for UTI
complications (OR= 6.4; 95% CI 4.6–9.0). In low-risk patients, 91% received antibiotics that
were recommended in the guideline. For high-risk patients this percentage ranged widely, and
was particularly low in the risk groups with signs of tissue invasion (29–50%). Diagnostic and
therapeutic adequacy can still be improved by increasing the adherence to the guideline in
UTI patients at high risk for complications. This may contribute to containing antibiotic
resistance in UTI by ordering urine cultures and use the results to adjust prescriptions to
antibiotic susceptibility of the uropathogen.
Introduction
Resistance to antibiotics is a worldwide problem, which may be reduced by prescribing less
antibiotics and reducing inappropriate prescriptions (Wise et al., 1998; Butler et al., 2007).
More than 90% of antibiotics in Europe are prescribed in primary care (Goossens et al., 2005).
For urinary tract infections (UTIs) the initial prescription of antibiotics is usually ‘blindfolded’,
without knowing the causing uropathogen and its susceptibility to antibiotics. This is con-
sidered sufficient for healthy non-pregnant women, because of the high prevalence of uro-
pathogen Escherichia coli and its susceptibility to nitrofurantoin and fosfomycin (Den Heijer
et al., 2010). However, there are several groups of patients, including pregnant women and all
men, who are at high risk for UTI complications (pyelonephritis, prostatitis or urosepsis)
because of different uropathogens or immunosuppression. Therefore, the guideline of Dutch
College of General Practitioners (GPs) on UTI (NHG-guideline) (Van Pinxteren et al., 2013)
recommends a urine culture and specific antibiotics for these high-risk patients. If a culture is
ordered, the guideline recommends that antibiotics should be started empirically in antici-
pation of the culture result, after which a switch can be made if resistance is seen. This Dutch
guideline is very similar to the UK guideline for GPs (Health Protection Agency, 2011), with
the exception of two risk factors: recurrent UTI is not considered a risk factor for compli-
cations in the Dutch guideline, whereas, on the other hand, immune disorders are not
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mentioned in the UK guideline (Health Protection Agency, 2011).
The two guidelines are quite similar regarding antibiotic recom-
mendations. Both guidelines advise nitrofurantoin and tri-
methoprim as first choice antibiotics for low-risk patients,
however, the Dutch guideline also includes fosfomycin. In addi-
tion, in the Dutch guideline co-amoxiclav is the second choice
instead of amoxicillin for any patient without tissue invasion and
co-trimoxazole for patients with tissue invasion.
In Dutch general practice, resistance to the recommended
antibiotics varied from 2% (nitrofurantoin) to 26% (trimetho-
prim) for the most common uropathogen E. coli in cultures (De
Greeff et al., 2015).
In most countries, studies mainly focus on treatment of UTI
and rarely on use of cultures in general practice. A Spanish GP
study shows that for 33% of low-risk patients a culture is ordered,
even though not meeting the national guideline criteria for a
culture (Llor et al., 2011). A study among GPs in the UK shows a
culture was ordered in 40% of low-risk patients and in 39–98% of
high-risk patients, depending on risk factor.
When prescribing antibiotics for UTI, only 42% (Braspenning
et al., 2004) to 50% (Van Bergeijk and Berger, 2008) of Dutch GPs
appear to adhere to the therapeutic recommendations in the
national guideline. The current guideline on UTI is well-known
among GPs in The Netherlands, but a study also showed that
Dutch GPs still perceive several barriers implementing this
guideline, like unavailable diagnostic materials or unavailable
dosages of medication (Lugtenberg et al., 2010).
To support a more rational prescription of antibiotics in pri-
mary care, more data are needed on current use of cultures and
related to this, antibiotic prescriptions. Therefore, our aim is to
identify subgroups of UTI patients in which the use of urine
cultures and antibiotic prescriptions deviates from the guidelines.
We also investigate the influence of established risk factors for
UTI complications (eg pregnancy, immunodeficiency), common
comorbidities (like cardiovascular or pulmonary diseases), age
and a history of recurrent UTI on urine culture requests.
Methods
This is an observational study using anonymous electronic patient
records (EPR) from seven practices (24 GPs and 30,452 patients)
from the Family Medicine Network (FaMe-Net). This is a
practice-based research network from the Radboud University
Medical Centre in Nijmegen, The Netherlands. FaMe-Net origi-
nates from a fusion between the Continuous Morbidity Regis-
tration (Van Weel, 2008) and Transitionproject (Okkes et al.,
2005). Of seven practices, three practices are located in Nijmegen
(Southeast; urban and semi-urban area), two practices in
Amstelveen (West; semi-urban area), one in Olst (East; rural area)
and one in Franeker (North; rural area). The study practices are
representative to Dutch practices in terms of average patient
population size, male-to-female GP ratio and proportion of
practices that include GP trainees (CBS Statistics Netherlands;
Netherlands Institute for Health Services Research (NIVEL)).
However, the majority of our study practices are group practices
consisting of three or more GPs, whereas fewer solo or duo
practices are included in comparison to the general practices
across The Netherlands. The patient population in this network is
representative of the general Dutch population in terms of age
and sex (CBS Statistics Netherlands). Participating GPs have
special interest in primary care research and code each episode of
care according to the International Classification of Primary Care
(ICPC) (Hofmans-Okkes and Lamberts, 1996). An episode of care
is defined as a health problem in an individual from the first to
the last visit related to the specified health problem. All actions
from the GP, including physical examination, diagnostic tests and
prescriptions, are systematically coded. The validity of registration
is high, as participating GPs meet regularly to discuss registration
and diagnostic criteria. Moreover, the system warns the GP in
case of error or inconsistency in registration. Research with
FaMe-Net data is exempted from ethical review by the CCMO
(Dutch Central Committee on research involving human
subjects).
The study population included all patients with ICPC codes
U71 (cystitis), U70 (pyelonephritis) or Y73 (prostatitis) that
presented to their GP in 2015 (n= 1295). If patients had multiple
UTIs, only the first diagnosis in 2015 was included.
Definition of risk for UTI complication
The risk of UTI complications was classified according to the
Dutch national guideline on UTI and is summarized in Table 1
(Van Pinxteren et al., 2013). High-risk patients had at least one of
the risk factors. Consequently, low-risk patients include all
patients with an UTI without any of these high-risk criteria.
Data extraction
Data from the EPR were extracted in two steps. In step one, a
data set including all ICPC codes registered in 2015 were
extracted to identify patients that presented with a UTI to their
GP in 2015. In step two, complete data from all available years
before 2015 were extracted for all selected UTI patients. Data
were extracted from the EPR, which contains ICPC codes
(diagnosis), Anatomical Therapeutic Chemical (ATC) codes
(medication prescriptions using Anatomical Therapeutic Che-
mical classification system), intervention codes, laboratory codes,
written lines by the GP and letters from other (medical) profes-
sions. For each subject the characteristics that matched the cri-
teria for a risk group were classified, using a combined list of
ICPC, ATC and laboratory codes and keywords (see Appendices
I, II and III for full list).
Urine cultures
We extracted data on all urine cultures ordered one day before
UTI diagnosis until 14 days after, by an electronic search of the
written lines in the EPR and by screening the letters from
microbiologists and laboratories.
Medical history
We retrieved data on common comorbidities (other than risk
factors for complications of UTI) with a list of ICPC codes (see
Appendix II) using full medical history data in the EPR.
Comorbidities included cardiovascular and pulmonary disease,
inflammatory bowel diseases, thyroid dysfunctions, rheumatoid
arthritis, dementia and diseases of the nervous system.
Recurrent UTI was defined as three or more UTIs in the
preceding 12 months (Epp et al., 2010).
Statistical analysis
The main outcome was the order of a culture, and the main
determinants were subgroups at high risk for complications of
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UTI, comorbidities, history of recurrent UTI and age groups
compared with the largest age group of 45–64 years. We cate-
gorized age of patients into seven groups for analyses. We ana-
lysed the association between urine culture orders and each of the
above-described patient characteristics individually with an
unadjusted logistic regression analysis. An adjusted logistic
regression model, where all the above-described characteristics
were entered simultaneously, was used to identify which factors
contributed independently. We evaluated the compliance of
GPs to the national guideline (Van Pinxteren et al., 2013) for the
use of urine cultures and the type of prescribed antibiotics with
descriptive statistics and χ2-tests. All analyses were performed
using SPSS version 22. A P-value of < 0.05 was considered sta-
tistically significant.
Results
Patient characteristics
In total, 530 (40.9%) patients had one or more risk factors for
complications of UTI (Table 1). The most common high-risk
Table 1. Characteristics of study population and likelihood of urine culture request in subgroups (n= 1295)
n (%) Cultures / n (%)
Unadjusted ORc
(95% CI)
Adjusted ORd
(95% CI)
Total 1295 (100) 221/1295 (17.1) − −
Low-risk for complications 765 (59.1) 52/765 (6.8) − −
High-risk (>1 risk factor)a 530 (40.9) 169/530 (31.9) 6.4 (4.6–9.0) −
Male 175 (13.5) 69/175 (39.4) 4.1 (2.9–5.9) 6.2 (4.0–9.6)
Symptoms of tissue invasion 163 (12.6) 54/163 (33.1) 2.9 (2.0–4.1) 1.7 (1.1–2.6)
Immune disorder 153 (11.8) 27/153 (17.6) 1.0 (0.7–1.6) 0.9 (0.5–1.6)
Renal/bladder disease 142 (11.0) 35/142 (24.6) 1.7 (1.1–2.6) 1.4 (0.9–2.3)
Age <12 years 70 (5.4) 39/70 (55.7) 7.2 (4.4–11.9) 9.9 (5.4–17.8)
Pregnancy 45 (3.5) 23/45 (51.1) 5.6 (3.0–10.1) 12.8 (6.3–26.1)
Indwelling catheter 30 (2.3) 8/30 (26.7) 1.8 (0.8–4.1) 0.7 (0.3–1.8)
Antibiotic prophylaxis 4 (0.3) 3/4 (75.0) 14.8 (1.5–142) 31.6 (3.0–332)
Comorbidity (≥1 present) 485 (37.5)
Cardiovascular disease 263 (20.3) 37/263 (14.1) 0.8 (0.5–1.1) 0.6 (0.3–1.1)
Pulmonary disease 196 (15.1) 27/196 (13.8) 0.7 (0.5–1.2) 0.8 (0.5–1.3)
Thyroid dysfunction 80 (6.2) 12/80 (15.0) 0.8 (0.5–1.6) 1.4 (0.7–2.8)
Nervous system 30 (2.3) 6/30 (20.0) 1.2 (0.5–3.0) 0.5 (0.2–1.6)
Rheumatoid arthritis 27 (2.1) 4/27 (14.8) 0.8 (0.3–2.5) 1.6 (0.5–4.9)
Dementia 22 (1.7) 7/22 (31.8) 2.3 (0.9–5.7) 3.9 (1.3–11.4)
Inflammatory bowel 18 (1.4) 4/18 (22.2) 1.4 (0.5–4.3) 1.5 (0.3–4.7)
Recurrent UTI 99 (7.6) 21/99 (21.2) 1.3 (0.8–2.2) 1.9 (1.1–3.4)
Age (years)b
12–18 36 (2.8) 8/36 (22.2) 1.6 (0.7–3.7) 2.1 (0.9–5.2)
19–24 97 (7.5) 8/97 (8.2) 0.5 (0.2–1.1) 0.7 (0.3–1.6)
25–44 332 (25.6) 51/332 (15.4) 1.0 (0.7–1.6) 0.8 (0.5–1.3)
45–64 366 (28.3) 55/366 (15.0) 1.0 1.0
65–74 155 (12.0) 21/155 (13.5) 0.9 (0.5–1.5) 0.9 (0.5–1.5)
>75 239 (18.5) 39/239 (16.3) 1.1 (0.7–1.7) 1.0 (0.5–1.8)
aPatients with multiple risk factors are included for each risk factor.
bFor age 0–12 months, see risk factor ‘Age <12 years’.
cStatistically significant results are printed in bold. OR present the likelihood of a urine culture being requested in patients with that characteristic compared with all other patients without
that specific characteristic.
dOR are adjusted: models include all risk factors, all comorbidities, a history of recurrent UTI and age groups compared with the largest age group of 45–64 years simultaneously.
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characteristic was male gender (13.5%), followed by symptoms of
tissue invasion (12.6%), immune disorders (11.8%) and renal/
bladder diseases (11.0%). Selected comorbidities were present in
37.5% of patients, and 7.6% of patients had a history of
recurrent UTI.
Urine cultures
A urine culture was ordered in 221 patients (17.1%) (Table 1).
Urine cultures were more commonly ordered in high-risk (31.9%)
than low-risk patients (6.8%) (OR= 6.4, 95% CI 4.6–9.0).
Table 2. Antibiotic prescriptions for UTI in subgroups at risk for UTI complications, compared with recommended prescriptions in the Dutch GP guideline (Van
Pinxteren et al., 2013)
Antibiotic prescription, n (%)
According to guideline First choicec Second/third choiced Not according to guideline Not prescribed
Low-risk for complications, n= 765 699 (91.4) 618 (80.8) 81 (10.5) 35 (4.6) 31 (4.1)
High-risk, n= 530a
Children (age <12 years)
No tissue invasion, n= 48 44 (91.7) 38 (79.2) 6 (12.5) 1 (2.1) 3 (6.3)
With tissue invasion, n= 20 13 (65.0) 12 (60.0) 1 (5.0) 5 (25.0) 2 (10.0)
Pregnant
No tissue invasion, n= 40 32 (80.0) 27 (67.5) 5 (12.5) 1 (2.5) 7 (17.5)
With tissue invasion, n= 5 Unknown e Unknown 0 3 (60.0) 2 (40.0)
Non-pregnant, aged >12 yearsb
Men
No tissue invasion, n= 114 57 (50.0) 52 (45.6) 5 (4.4) 48 (42.0) 13 (11.4)
With tissue invasion, n= 55 43 (78.2) 32 (58.2) 11 (20.0) 7 (12.7) 5 (9.1)
Immune disorder
No tissue invasion, n= 13 8 (61.5) 8 (61.5) 0 4 (30.8) 1 (7.7)
With tissue invasion, n= 8 3 (37.5) 3 (37.5) 0 3 (37.5) 2 (25.0)
Indwelling catheter
No tissue invasion, n= 21 8 (38.1) 8 (38.1) 0 12 (57.1) 1 (4.8)
With tissue invasion, n= 7 2 (28.6) 1 (14.3) 1 (14.3) 3 (42.9) 2 (28.6)
Renal/bladder disease
No tissue invasion, n= 120 72 (60.0) 62 (51.7) 10 (8.3) 39 (32.5) 9 (7.5)
With tissue invasion, n= 20 10 (50.0) 8 (40.0) 2 (10.0) 6 (30.0) 4 (20.0)
Antibiotic prophylaxis
No tissue invasion, n= 4 4 (100.0) f 0 0 0 0
With tissue invasion, n= 0 – – – – –
Other
No tissue invasion, n= 0 – – – – –
With tissue invasion, n= 64 23 (35.9) 15 (23.4) 8 (12.5) 41 (64.0) 0
(NHG=Nederlands Huisartsen Genootschap/Dutch College of General Practitioners)
aFor each high-risk group, patients with and without tissue invasion are distinguished because of different antibiotic recommendations in NHG-guideline.
bPatients with multiple risk factors are included for each risk factor.
cFirst choice antibiotic is nitrofurantoin for all subgroups, except for patients with tissue invasion where first choice is co-amoxiclav in children aged <12 years, and ciprofloxacin in other
patients with tissue invasion. Pregnant women with tissue invasion are recommended to be referred to hospital.
dSecond choice antibiotic is fosfomycin (low-risk patients), co-amoxiclav (children without tissue invasion/pregnant women without tissue invasion/non-pregnant patients aged >12 years
with tissue invasion), co-trimoxazole (children with tissue invasion), trimethoprim (non-pregnant patients aged >12 years without tissue invasion); third choice antibiotic is only listed for
low-risk patients (ie trimethoprim) and non-pregnant patients aged >12 years with tissue invasion (ie co-trimoxazole).
eThere were no data available due to referrals from hospital (as recommended in guideline).
fNational GP guideline advises a switch in antibiotics.
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Relatively more cultures were ordered in patients that used
antibiotic prophylaxis (75.0%), followed by patients aged under
12 (55.7%), and pregnant women (51.1%), although fewer cul-
tures were ordered in patients with an indwelling catheter
(26.7%), renal/bladder disease (24.6%) or immune disorder
(17.6%).
As expected, urine culture orders were more common among
several subgroups of patients at high risk for complications.
Adjusted analyses (including all risk factors for complications,
comorbidities, a history of recurrent UTI and age) show that
urine cultures were significantly more often ordered in patients
with antibiotic prophylaxis (OR= 31.6), pregnancy (OR= 12.8),
age <12 years (OR= 9.9), male (OR= 6.2) or symptoms of tissue
invasion (OR= 1.7) compared with patient groups without these
characteristics, respectively (see Table 1). Strikingly, urine cul-
tures were not more often ordered in patients with immune
disorder, renal/bladder disease or an indwelling catheter, whereas
these patients are also at high risk for complications of UTI, and
the national guideline recommends urine cultures in these
patients. In addition, culture orders were significantly more
common in patients with recurrent UTI (OR= 1.9) and dementia
(OR= 3.9), compared with those without recurrent UTI or
dementia, respectively. There was no statistically significant
influence of age or other comorbidities on urine culture orders.
In 6.8% of low-risk patients, a urine culture was ordered. In
the low-risk group urine cultures were more common in patients
with dementia (OR= 8.3; 95% CI 1.8–38.3, results not shown).
None of the other comorbidities, age or recurrent UTI had a
statistically significant effect on urine culture orders.
Among high-risk patients, we found no influence of comor-
bidities, age or recurrent UTI on urine culture orders (results not
shown).
Antibiotics
Almost all UTI patients (94%) were prescribed antibiotics, mostly
nitrofurantoin (68.7%), followed by ciprofloxacin (8.8%) and
fosfomycin (6.5%). In the low-risk group, 31 (4.1%) patients did
not receive antibiotics, compared with 47 (8.9%) in the high-risk
group (P-value <0.001). As shown in Table 2, recommended
antibiotics (first, second or third choice in the guideline) were
prescribed to 91.4% of low-risk patients. For high-risk patients
adherence to the recommended antibiotics varied strongly by risk
factor. Higher adherence was seen in children and pregnant
women without tissue invasion, 91.7 and 80.0%, respectively.
Lower adherence was observed in men without tissue invasion
(50%) and high-risk (non-pregnant female) patients with tissue
invasion (range 28.6–50.0%) (see Table 2).
Discussion
Most important findings
This study shows a low percentage (32%) of urine culture ordered
in patients with risk factors for complications of UTI. Culture
orders were particularly low in patients with immune disorder
(18%), renal/bladder disease (25%) or an indwelling catheter
(27%). Antibiotics were prescribed to the majority of patients
(94%), but compliance to the national guideline varied broadly by
risk factor for complications (29–92%).
Strengths and limitations
One of the major strengths is the high-quality of recording in this
cohort, as inconsistency in registration is flagged by the system
and GPs from the network discuss registration issues regularly.
Also, the number of patients with an UTI included in our study
was high (n= 1295) and we had access to individual patient data
from the EPR. This is the first study in The Netherlands that
examined urine culture orders for UTI in general practice, iden-
tifying patient characteristics in whom a culture was more fre-
quently ordered.
There are several limitations worth mentioning. First, the time
period in which temporary risk factors (pregnancy and indwelling
catheter) were present had to be estimated. Therefore, we com-
pared the prevalence of these risk factors with those found in the
literature, and were found to correspond to our figures. Van
Bergeijk and Berger (2008) found 3.1% pregnant patients with
UTI in Dutch general practice (compared with 3.5% in our
study). Indwelling catheter appeared in 3% of female patients in
the study of Hummers-Pradier et al. (2005), compared with 2.3%
in our study. For indwelling catheters, we assumed a standard use
of 12 weeks. Patients who had their catheter removed sooner are
potentially misclassified as high risk, which may (partly) explain
the lower rate of urine culture orders in this group. Second, it was
not possible to identify patients with ‘failure of two blindfolded
antibiotic prescriptions’, which is listed as an additional risk
factor for complications of UTI in the national guideline, because
we were not able to distinguish in the EPR if symptoms had
disappeared or continued between two prescriptions for anti-
biotics. Third, the result of slightly more patients in the high-risk
group that did not receive antibiotics (8.9% compared with 4.1%
in the low-risk group) was unexpected. This finding might be
partially explained, by having misclassified some patients as high
risk (ie not all patients with malignancies received chemotherapy/
radiotherapy, as we have assumed). Also, some high-risk patients
may have been referred to hospital and were prescribed anti-
biotics by a medical specialist, which is not registered in the EPR
in general practice. Lastly, the GPs in our database were all part of
the FaMe-Net practices, which are GPs with special interest in
research and have frequent meetings to optimize accurate regis-
tration in the EPR, so perhaps the compliance with the guideline
is higher than among other GPs.
Comparison to other literature
In comparison with the study by Llor et al. (2011) in Spain, who
found that GPs ordered urine cultures in 33% of low-risk patients,
the GPs in our study performed better by ordering fewer cultures
in low-risk patients (7%). This might be because of the absence of
dipslides in the Spanish study population, which means the only
available diagnostic tool is a culture.
Ironmonger et al. (2016) questioned GPs in the UK on the use
of urine culture in patients with and without risk factors. As we did,
they found a notable difference in culture orders in low-risk (40%)
and high-risk patients, with differences by risk factor (38% for
indwelling catheter to 98% for male patients). However, they
investigated only a selection of risk factors in five hypothetical
patients, making it difficult to compare the reported percentages
with our data. In comparison with a Dutch study by Den Heijer
et al. (2010), who investigated the antibiotic prescription rate by
GPs for low-risk patients with UTI and the susceptibility of E. coli
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to common antibiotics, the percentage of antibiotic prescriptions
corresponding to the guideline for low-risk patients in our study is
higher, namely 91% compared with 77%. This might be partially
due to the continuing decrease in use of quinolones for low-risk
patients, as has been advised in the national guideline since 2005.
Implications
Both diagnostic and therapeutic adequacy could be improved,
which is implicated by the relatively low percentage of culture
orders and high use of inappropriate antibiotics (ie non-
recommended in the guideline) in several subgroups of high-
risk patients. This is worrying because resistance to commonly
prescribed antibiotics in the high-risk group is often seen (De
Greeff et al., 2015). Not ordering a urine culture in high-risk
patients can have several reasons, for example, the GP is not
aware of all risk factors for complications of UTI, the GP might
not see the benefit of a culture owing to experience and the low
incidence of complications, or possibly the patient does not want
a culture because of financial costs. The underlying motives for
not ordering cultures should be further explored.
The percentage of culture orders in low-risk patients is
relatively low (7%), but not 0% as would have been expected
with perfect compliance to guidelines. This group might still
contain some high-risk patients with risk factor ‘failure of two
blindfolded given antibiotics’, which we have not been able to
identify. Furthermore, we found that patients with dementia are
more likely to get a culture order. In case of an unexplained
fever in patients with dementia, a urine culture might be rou-
tinely performed to find the cause. Moreover, owing to a diffi-
cult anamnesis, the efficacy of antibiotics is hard to monitor in
these patients, so a urine culture may contribute in evaluating
treatment effects. As dementia is not specifically mentioned in
the guideline, it would be of interest to investigate the reasons of
GPs for performing more cultures in this patient group, and its
potential value.
For high-risk patients the adherence to recommended anti-
biotics varied strongly by risk factor. Reasons for non-adherence
should be further explored, focussing both on GP-related factors
and patient influences. It is unknown whether the lower rates of
adherence in some subgroups of patients are based on inten-
tional or non-intentional decisions by GPs or driven by patient
requests.
The Dutch GP guideline on UTI is currently under revision,
and our findings imply the need of critical review of current
policies, particularly in the highlighted subgroups. As non-
adherence is low in subgroups of patients, future revisions of
the guideline should evaluate current policies and include
information on the cost-effectiveness of urine cultures in spe-
cific subgroups of patients and address issues related to non-
adherence.
In conclusion, in The Netherlands urine cultures are ordered
by GPs in only a third of patients at high risk for complications of
UTI, even though the guideline recommends cultures in all high-
risk patients. Antibiotics were prescribed to nearly all patients, but
compliance to the national guideline varied a lot by risk factor.
Diagnostic and therapeutic adequacy can be improved in UTI
patients at high risk for complications by ordering more cultures
and adjust prescriptions to antibiotic susceptibility of the uro-
pathogen, and improve antibiotic prescriptions adhering to the
national guideline. This may contribute to containing antibiotic
resistance in UTI.
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Appendix I: Additional information on methods
Full definition for immunocompromised patients
Immune disorders include diabetes mellitus, the use of chemotherapy
or radiotherapy (defined as a malignancy in the previous two years* for
which those are commonly received), use of immunosuppressants
or immunostimulants, and a medical history with immune deficiencies,
AIDS/HIV, splenectomy or a received organ transplantation.
*According to the Health Council of The Netherlands (Van Pinxteren
et al., 2013), most of the treatment and short-term follow-up with specialized
care in the hospital takes place within the first and second year after diagnosis
of a malignancy. Therefore, we consider patients within the first two years
after diagnosis of a malignancy for which chemotherapy or radiotherapy is
often given, to be immunocompromised, owing to the high chance of receiving
either treatments.
Electronic search with keywords
Risk factors, comorbidities and diagnostic tests in the written lines of the EPR
appeared in the database as free text and were searched using the following
protocol to optimize standardized data extraction. The free text was searched
electronically for keywords, with the use of iterative processing (ie including
additional keywords based on interim checks) to fine tune the result. To find the
absence or presence of a symptom or test, different positive and negative prefixes
and suffixes were used in addition to searches with the single keywords. Spelling
errors in keywords were anticipated and overcome by testing possible errors. The
final result of the electronic search was checked with random samples and proved
to be of good quality.
Classifying diabetes
In the NHG-guideline, it is described that otherwise healthy women with
diabetes may be considered as low risk for complications of UTI. After
selection of all female patients with diabetes, but with no other comorbidities,
no risk factor and aged under 60 (Health Protection Agency, 2011), we
identified only three patients and we have therefore chosen to classify all
diabetic patients as high risk.
Other
∙ The date of all given ICPC and ATC codes for risk factors and comor-
bidities had to occur before the date of the UTI of that patient, in order to
be included in the analysis.
∙ All patients had to be subscribed to the practice for the full period of data
collection.
∙ In case a patient had a culture found in multiple ways, the most extensive
or detailed one was used.
Appendix II: ICPC codes used to identify comorbidities
Comorbidity
ICPC
code Description
Cardiovascular disease K74 Ischaemic heart disease with
angina
K75 Acute myocardial infarction
K76 Ischaemic heart disease without
angina
K77 Heart failure
K78 Atrial fibrillation/flutter
K80 Cardiac arrhythmia NOS
K82 Pulmonary heart disease
K83 Heart valve disease NOS
K84 Heart disease other
K89 Transient cerebral ischaemia
K90 Stroke/cerebrovascular
accident
K91 Cerebrovascular disease
K93 Pulmonary embolism
Pulmonary disease R95 Chronic obstructive pulmonary
disease
R96 Asthma
Inflammatory bowel diseases D94 Chronic enteritis/ulcerative
colitis
Thyroid dysfunctions T85 Hyperthyroidism/thyrotoxicosis
T86 Hypothyroidism/myxoedema
Rheumatoid arthritis L88 Rheumatoid/seropositive
arthritis
Dementia and diseases of the
nervous system
N86 Multiple sclerosis
N87 Parkinsonism
N88 Epilepsy
P70 Dementia
NOS = Not Otherwise Specified
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Risk factor Definition Data extraction
Male gender General information from EPR
Symptoms of tissue
invasion
Fever, chills, malaise, flank or perineal pain, acute
confusion or delirium
Laboratory codesa for patient’s temperature were used and the
written lines in the EPR were electronically searched for keywordsa
on symptoms of tissue invasion. Also, ICPC U71 pyelonephritis, Y73
acute prostatitis and urosepsis were used
Immune disorders Including diabetes mellitus, immunosuppressant
drugs, medical history with immune disorders
and malignancies in the past two years with high
change of receiving chemotherapy/radiotherapy
The use of immunosuppressant/stimulant medication was based
on ATC codes in EPR. Time period of usage was calculated with
dosage per day and amount of prescribed medication. A list of
ICPC codesa was used for immune disorders and malignancies
Renal/bladder disease Including severe renal insufficiency (GFR< 30),
renal cysts, renal lithiasis, neurological bladder
disorders, urinary retention, prostatism
A list of ICPC codesa was used for renal/bladder diseases, as well
as the most recent GFR before the UTI
Age <12 years General information from EPR
Pregnancy In any trimester A list of ICPC codesa was used. If an ICPC delivery code was
present, the estimated time of pregnancy was 280 days before
date of delivery. If only a pregnancy code was present, it was
assumed that women presented to their GP for the first time four
weeks into pregnancy
Indwelling catheter Presence of indwelling urinary catheter Both an electronic search of written lines in EPR for keyword
‘catheter’ was performed and the EPR prescription list was used.
For each prescribed catheter on the medication list 12 weeks
(maximum time period for one catheter) were added to the date of
prescription, to estimate the time period of presence
Antibiotic prophylaxis Trimethoprim 50–100mg or nitrofurantoin 50mg
once a day as prophylaxis for UTI
ATC codesa in EPR were used. The time period during which
prophylaxis was used was calculated based on the number of
prescribed tablets
Failure of two ‘blindfolded’
prescribed antibiotics
It was not possible to reliably find the presence of this risk factor
in EPR
(EPR= electronic patient record; ICPC code= International Classification of Primary Care code; ATC code= Anatomical Therapeutic Chemical classification code; GFR= glomerular
filtration rate)
aA full list of ICPC, ATC, laboratory codes and keywords is available from corresponding the author.
Appendix III: Definitions of risk factors for complications of UTI, according to the NHG-guideline and description of
data extraction
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